Aktuelle Therapiekonzepte bei der abdominellen Sepsis

[1]  R. Hutchins,et al.  Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery , 2004, World Journal of Surgery.

[2]  C. Sprung,et al.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. , 2003, JAMA.

[3]  D. Tweardy,et al.  Intra-Abdominal Activation of a Local Inflammatory Response Within the Human Muscularis Externa During Laparotomy , 2003, Annals of surgery.

[4]  M. Zinner,et al.  Ileus and the macrophage. , 2003, Annals of surgery.

[5]  Licheng Wu,et al.  Influence of the critically ill state on host-pathogen interactions within the intestine: Gut-derived sepsis redefined , 2003, Critical care medicine.

[6]  D. Gouma,et al.  Meta‐analysis of relaparotomy for secondary peritonitis , 2002, The British journal of surgery.

[7]  H. Bruining,et al.  Future directions in the management of tertiary peritonitis , 2002, Intensive Care Medicine.

[8]  H. Burchardi,et al.  Burden of illness imposed by severe sepsis in Germany , 2002, The European Journal of Health Economics.

[9]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[10]  R. Larsen.  Multiorganversagen – Licht am Ende des Tunnels? , 2001, Der Anaesthesist.

[11]  J. Marshall,et al.  Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome , 2001, Critical care medicine.

[12]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[13]  A. Meier-Hellmann.  Katecholamintherapie in der Sepsis , 2000, Der Anaesthesist.

[14]  J. Marshall,et al.  Vasoactive agents and the gut: fueling the motor of multiple organ failure. , 2000, Critical care medicine.

[15]  M. Büchler,et al.  Conservative surgical treatment of diffuse peritonitis. , 2000, Surgery.

[16]  J. Siewert,et al.  Current and Future Concepts of Abdominal Sepsis , 2004, World Journal of Surgery.

[17]  H. Bartels.  Das Translokationsphänomen als Problem der Ileuskrankheit , 2003 .

[18]  H. Bartels.  Postoperative Komplikationen - Was ist haufig? Was ist selten? , 2001 .

[19]  S. Opal,et al.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. , 2001, JAMA.

[20]  J. Marshall,et al.  Clinical trials of mediator-directed therapy in sepsis: what have we learned? , 2000, Intensive Care Medicine.